Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer

Fig. 1

High expression of BACH1-IT2 in bladder cancer. A Real-time PCR quantitation of relative expression of BACH1-IT2 transcript in bladder tumors and paired adjacent normal tissues (n = 100, from the Longgang District People’s Hospital of Shenzhen). B Expression analysis of BACH1-IT2 in bladder cancers (T = 404) and normal controls (N = 28) in public database (Gepia). C Kaplan–Meier survival curve of bladder cancer patients subgrouped into high (n = 206) and low (n = 198) BACH1-IT2. D Correlation analysis of relative BACH1-IT2 levels with tumor stage of bladder cancer panel (n = 100). E Quantitative PCR analysis of relative expression of BACH1-IT2 in panel of bladder cancer cell lines including HT1197, SW780, 5637, RT4, UMUC3, T24 and immortalized urothelial cell line TRT-HU1. F Subcellular localization of BACH1-IT2 was determined by fractionization analysis with GAPDH as a cytosol marker and U6 as a nucleus marker, respectively

Back to article page